GlassScriptPhysician profile
Heather D Strawbridge
NPI 1083928931
$1,440.01
in general payments reported to CMS, 2019-2025
19 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $104 · 2021: $129 · 2022: $47.72 · 2023: $26.18 · 2024: $305 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $477.95 | 2019-2025 | Tezspire, Fasenra |
| Vertex Pharmaceuticals Incorporated | $245.66 | 2019-2024 | Trikafta |
| Glaxosmithkline, LLC. | $109.05 | 2019-2020 | |
| Genentech USA, INC. | $106.12 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $81.81 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $55.18 | 2019-2025 | Dupixent |
| Chiesi USA, INC. | $49.87 | 2019-2022 | |
| Sobi, INC | $42.57 | 2019 | |
| Abbvie INC. | $40.99 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.03 | 2019 | |
| Amgen INC. | $38.63 | 2024 | Tezspire |
| Teva Pharmaceuticals USA, INC. | $35.08 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $23.91 | 2019 | |
| Harmony Biosciences LLC | $17.82 | 2025 | |
| Advanced Respiratory, INC | $17.50 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $15.32 | 2021 | |
| Genzyme Corporation | $15.31 | 2020 | |
| Baxter Healthcare | $14.54 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Gilead Sciences, INC. | $13.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Strawbridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.